Key result
Portable ECG6L device captures high-quality six-lead ECGs via three electrodes for real-time smartphone monitoring.
Why the study?
Existing self-monitoring heart devices often fail to provide a comprehensive cardiac diagnosis, commonly offering only numerical data or single-lead ECGs.
The development of a portable, wireless six-lead ECG device could improve remote monitoring and early diagnosis of cardiovascular diseases.
May aid remote ECG access in underserved settings; leaves open prospective clinical validation trials.
Cardiovascular diseases (CVDs) have significant impacts on health, quality of life and economics, being the major cause of death and disability worldwide. Also in Europe, CVDs are the leading cause of death, accounting for 45% of all deceases with an estimated cost of 210 billion of euros annually. Addressing CVDs through prevention and monitoring is crucial to improve health expectancy and reducing the economic burden of these diseases. Several devices allow for self monitoring of heart activity but many of them are not designed to provide a comprehensive diagnosis of cardiac conditions, commonly providing just numerical information about heart activity and, less frequently, reporting a single-lead electrocardiogram (ECG). This paper aims to present a portable device capable to overcome these limitations, delivering a six leads medical ECG in a non-invasive way. The combined use of digital and analog filtering of the signals acquired via three electrodes, made it possible to create a device capable of acquiring a high-quality six-lead ECG while maintaining an extremely compact design. The integration with the smartphone application allows the storing of ECG data for future analysis and references; moreover, the possibility of sharing data sets the basis for fast and efficient diagnosis of heart diseases.
No takes yet. Share an insight, caveat, or question.
Randazzo et al. (2025) studied Cardiovascular diseases. ECG6L portable six-lead ECG was evaluated. The ECG6L portable device successfully acquires a high-quality six-lead ECG using three electrodes and integrates with a smartphone application for real-time monitoring and data sharing.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: